硅谷银行-2020年第四季度风险监测报告（英文）-2021.2-35页_4mb

Venture Monitor Q4 2020 Summary

Core Content

The Q4 2020 Venture Monitor report highlights the resilience and transformation of the US venture capital (VC) industry in the face of the ongoing COVID-19 pandemic. Despite macroeconomic headwinds, the industry achieved record-breaking investment levels, exits, and fundraising. The report provides an in-depth look at deal activity, sector trends, regional shifts, and the evolving role of investors in the ecosystem.

Main Points

• Record Investment: In 2020, the US VC industry saw a record $156.2 billion in total investment, with late-stage companies accounting for $28.8% of deal count and 66.7% of deal value.
• VC Exits: The exit market rebounded strongly in the second half of the year, with massive IPOs and acquisitions driving record liquidity. Notable exits include Airbnb and DoorDash's IPOs and Intuit's $7.1 billion acquisition of Credit Karma.
• Fundraising: The industry raised $73.6 billion in VC funds, with the median and average fund sizes increasing to $76.0 million and $235.8 million, respectively. Established fund managers secured 75% of this capital, showing a trend toward consolidation.
• Mega Deals: A record 321 mega-deals were closed in 2020, with late-stage companies contributing 265 of them. These deals accounted for $70.9 billion in value, or 45.4% of total deal value.
• SPAC Activity: SPAC activity surged in 2020, with 250 SPAC IPOs and $75.1 billion in value raised, representing a 579.6% increase from 2019. SPACs are seen as a viable alternative to traditional IPOs.
• Valuation Trends: Late-stage valuations and deal sizes increased significantly, while seed and angel valuations declined. This reflects a shift in investor focus toward more mature companies.
• Geographic Shifts: The Bay Area saw a decline in deal count, while other regions like Atlanta and Boston showed growth. This signals a potential shift in the geographic distribution of VC activity.
• Sector Performance:
  • Biotech & Pharma: Benefited from the pandemic-driven focus on vaccines and healthcare, with record deal activity and valuations. The sector is expected to continue its strong performance in 2021.
  • Fintech: Experienced record investment and rising valuations, though angel and seed activity was lower due to market uncertainty.
• Female Founders & Nontraditional Investors: These groups faced challenges in securing funding, as capital was largely directed toward existing portfolio companies and known relationships.
• Policy & Advocacy: The NVCA highlighted key policy initiatives, including the IGNITE American Innovation Act and support for the Clean Energy Revolution, to foster innovation and economic recovery.

Key Information

• Deal Count & Value:
  • Total deal value in 2020 exceeded $150 billion for the first time.
  • 3,195 early-stage deals were closed, with an estimated 3,572 total deals.
  • Late-stage deals accounted for 66.7% of total deal value.
• Exit Value:
  • VC-backed exits totaled $290.1 billion, marking the second-highest year on record.
  • Q4 saw the largest VC-backed IPOs and acquisitions, contributing significantly to the overall exit value.
• Fundraising:
  • $73.6 billion in capital was raised by VC funds in 2020, with a record number of mega-funds.
  • Established VC firms dominated fundraising, securing nearly 75% of the total capital raised.
• Digital Transformation:
  • The shift to digital dealmaking was swift and smooth, especially in the angel and seed stages.
  • This shift allowed for continued deal activity despite pandemic-related restrictions.
• Investor Behavior:
  • Investors increasingly focused on late-stage companies due to the stability and clarity of financial metrics.
  • Nontraditional investors remained active, contributing to late-stage deal growth.
• Future Outlook:
  • The industry is expected to continue its momentum in 2021, with a strong dry powder of $152 billion.
  • SPACs and direct listings are becoming more prominent alternatives to traditional IPOs.
  • There is a growing emphasis on diversifying investment geographies and supporting underrepresented founders.

Sector Highlights

• Biotech & Pharma:
  • Raised record capital, driven by the pandemic and increased interest in healthcare innovation.
  • Showed strong growth in both deal size and valuations, with a near-even split across investment stages.
  • Expected to maintain momentum in 2021 due to continued interest in vaccines and antivirals.
• Fintech:
  • Exceeded $20 billion in investment, with rising valuations and deal sizes.
  • Angel and seed activity declined, but late-stage deals expanded, contributing to overall sector growth.

Conclusion

The 2020 VC landscape was marked by resilience and adaptation, with late-stage companies and biotech & pharma sectors leading the charge. The shift to digital processes and the role of SPACs in providing alternative liquidity pathways were significant developments. While challenges remain for early-stage and underrepresented founders, the industry is well-positioned for continued growth in 2021, with a focus on innovation, policy advocacy, and geographic diversification.